Therosteon Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Merger of Eq.

Therosteon General Information

Description

Developer of therapies for bone diseases. The company develops therapies to cure bone diseases and is based on a technology with which it can develop new drug targets and therapies for various bone diseases, including osteoporosis and bone metastasis.

Contact Information

Website
therosteon.com
Ownership Status
Acquired/Merged
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • Rotterdam
  • Netherlands
Primary Industry
Biotechnology
Acquirer
Arcarios
Vertical(s)
Life Sciences
Corporate Office
  • Rotterdam
  • Netherlands

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Therosteon Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger of Equals 25-Aug-2010 Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2008 Completed Startup
To view Therosteon’s complete valuation and funding history, request access »

Therosteon Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Erasmus MC Biomedical Fund Venture Capital Minority
To view Therosteon’s complete investors history, request access »

Ready to get started?

Request a free trial

Therosteon FAQs

  • When was Therosteon founded?

    Therosteon was founded in 2008.

  • Where is Therosteon headquartered?

    Therosteon is headquartered in Rotterdam, Netherlands.

  • What industry is Therosteon in?

    Therosteon’s primary industry is Biotechnology.

  • Is Therosteon a private or public company?

    Therosteon is a Private company.

  • What is Therosteon’s current revenue?

    The current revenue for Therosteon is .

  • How much funding has Therosteon raised over time?

    Therosteon has raised $146K.

  • Who are Therosteon’s investors?

    Erasmus MC Biomedical Fund has invested in Therosteon.

  • When was Therosteon acquired?

    Therosteon was acquired on 25-Aug-2010.

  • Who acquired Therosteon?

    Therosteon was acquired by Arcarios.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »